肺部及播散性真菌病的当前治疗方法。 - Suppr

Suppr

超能文献

Current therapy of pulmonary and disseminated fungal diseases.

作者信息

Stamm A M, Dismukes W E

出版信息

Chest. 1983 Jun;83(6):911-7. doi: 10.1378/chest.83.6.911.

DOI:10.1378/chest.83.6.911

PMID:6303713

Abstract

摘要

相似文献

Current therapy of pulmonary and disseminated fungal diseases.

Chest. 1983 Jun;83(6):911-7. doi: 10.1378/chest.83.6.911.

[Commonly used antifungal agents in the treatment of systemic mycoses].

Rev Clin Esp. 1995 Oct;195 Suppl 3:58-65.

Oral antifungal therapy. Current status of ketoconazole.

Postgrad Med. 1983 Jan;73(1):52-3. doi: 10.1080/00325481.1983.11698312.

[Therapy of pulmonary mycoses].

Dtsch Med Wochenschr. 1992 Nov 6;117(45):1725-9. doi: 10.1055/s-2007-1024318.

Treatment of systemic mycoses.

Medicine (Baltimore). 1973 Sep;52(5):385-94. doi: 10.1097/00005792-197309000-00002.

Drug treatment of the systemic mycoses.

Semin Drug Treat. 1972 Winter;2(3):313-29.

Chemotherapy for the systemic mycoses: the prelude to ketoconazole.

Rev Infect Dis. 1980 Jul-Aug;2(4):625-32. doi: 10.1093/clinids/2.4.625.

Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Drugs. 1982 Jan-Feb;23(1-2):1-36. doi: 10.2165/00003495-198223010-00001.

Antifungal drugs.

J Antimicrob Chemother. 1975 Jun;1(2):141-62. doi: 10.1093/jac/1.2.141.

Treatment of systemic mycoses with miconazole: a review.

Mod Med Asia. 1977 Mar;13(3):9-11.

引用本文的文献

The lung in paracoccidioidomycosis: new insights into old problems.

Clinics (Sao Paulo). 2013 Apr;68(4):441-8. doi: 10.6061/clinics/2013(04)02.

Rhinocerebral invasive aspergillosis.

Indian J Otolaryngol Head Neck Surg. 1998 Jan;50(1):26-32. doi: 10.1007/BF02996763.

Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.

Antimicrob Agents Chemother. 2010 Jan;54(1):522-5. doi: 10.1128/AAC.01339-08. Epub 2009 Oct 19.

Systemic antifungal agents.

Tex Heart Inst J. 1990;17(3):194-202.

Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.

Antimicrob Agents Chemother. 1985 Dec;28(6):815-8. doi: 10.1128/AAC.28.6.815.

Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.

Antimicrob Agents Chemother. 1985 May;27(5):832-5. doi: 10.1128/AAC.27.5.832.

Adverse drug reactions to systemic antifungals. Prevention and management.

Drug Saf. 1992 Sep-Oct;7(5):323-63. doi: 10.2165/00002018-199207050-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Current therapy of pulmonary and disseminated fungal diseases.

Chest. 1983 Jun;83(6):911-7. doi: 10.1378/chest.83.6.911.

[Commonly used antifungal agents in the treatment of systemic mycoses].

Rev Clin Esp. 1995 Oct;195 Suppl 3:58-65.

Oral antifungal therapy. Current status of ketoconazole.

Postgrad Med. 1983 Jan;73(1):52-3. doi: 10.1080/00325481.1983.11698312.

[Therapy of pulmonary mycoses].

Dtsch Med Wochenschr. 1992 Nov 6;117(45):1725-9. doi: 10.1055/s-2007-1024318.

Treatment of systemic mycoses.

Medicine (Baltimore). 1973 Sep;52(5):385-94. doi: 10.1097/00005792-197309000-00002.

Drug treatment of the systemic mycoses.

Semin Drug Treat. 1972 Winter;2(3):313-29.

Chemotherapy for the systemic mycoses: the prelude to ketoconazole.

Rev Infect Dis. 1980 Jul-Aug;2(4):625-32. doi: 10.1093/clinids/2.4.625.

Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Drugs. 1982 Jan-Feb;23(1-2):1-36. doi: 10.2165/00003495-198223010-00001.

Antifungal drugs.

J Antimicrob Chemother. 1975 Jun;1(2):141-62. doi: 10.1093/jac/1.2.141.

Treatment of systemic mycoses with miconazole: a review.

Mod Med Asia. 1977 Mar;13(3):9-11.

引用本文的文献

The lung in paracoccidioidomycosis: new insights into old problems.

Clinics (Sao Paulo). 2013 Apr;68(4):441-8. doi: 10.6061/clinics/2013(04)02.

Rhinocerebral invasive aspergillosis.

Indian J Otolaryngol Head Neck Surg. 1998 Jan;50(1):26-32. doi: 10.1007/BF02996763.

Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.

Antimicrob Agents Chemother. 2010 Jan;54(1):522-5. doi: 10.1128/AAC.01339-08. Epub 2009 Oct 19.

Systemic antifungal agents.

Tex Heart Inst J. 1990;17(3):194-202.

Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.

Antimicrob Agents Chemother. 1985 Dec;28(6):815-8. doi: 10.1128/AAC.28.6.815.

Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.

Antimicrob Agents Chemother. 1985 May;27(5):832-5. doi: 10.1128/AAC.27.5.832.

Adverse drug reactions to systemic antifungals. Prevention and management.

Drug Saf. 1992 Sep-Oct;7(5):323-63. doi: 10.2165/00002018-199207050-00003.